At a glance
ClinicalIndex Comparison Record- ✓African American ethnicity
- ✓Age 50 to 65 years
- ✓Owns a working cell phone with unlimited texting capability
- ✓Ambulatory (able to walk)
- ✕History of neurological disorder or dementia diagnosis
- ✕Severe psychiatric disorder such as schizophrenia or bipolar disorder
- ✕History of insomnia
- ✕Cognitive impairment indicated by TICS score ≤20
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multidomain Approach to Preventing Dementia in African Americans: Cognitive Prescriptions
In Brief
A clinical study evaluating Cognitive Prescriptions for Cognitive Change and 2 related conditions. Completed, enrolled 39 participants across 1 site.
Detailed Summary
The goal of this R21 study is to explore the feasibility and preliminary efficacy of individualized cognitive prescriptions (CogRxs) in improving engagement in healthy behaviors and other outcomes in middle-aged AAs and to gain feedback on future implementation of the program.
Study Details
Timeline
Interventions
Personalized information on their risk factor profile across five CogRx domains (physical activity, cognitive activity, diet, sleep, social activity) and develop a tailored 3-month intervention plan, which will consist of simple evidence-based strategies to implement at home.